Chicago, Illinois. March 9, 2015. A patient at the University of Chicago Medicine was the first in the United States to be implanted with the HeartAssist5® Ventricular Assist Device (VAD) as part of an FDA clinical trial being conducted by Houston-based ReliantHeart, Inc. The HeartAssist5® VAD is a small mechanical pump implanted to support left… Read more »
ReliantHeart Inc. has been granted approval from the U.S. Food and Drug Administration Center for Devices and Radiological Health (FDA/CDRH) to conduct an Investigational Device Exemption (IDE) Clinical Trial on the HeartAssist5® Ventricular Assist Device System for patients awaiting a heart transplant.
Network Enabled HeartAssistRemote™ Honored for Improving Healthcare Delivery ATLANTA – August 8, 2014. Numerex (NASDAQ:NMRX), a leading provider of on-demand and interactive machine-to-machine (M2M) and Internet of Things (IoT) enterprise solutions, announced today that the HeartAssistRemote™ Monitoring System powered by Numerex has received a 2014 M2M Telehealth Award from M2M Evolution Magazine, the leading publication… Read more »
Houston, Texas, May 15, 2014. The ReliantHeart HeartAssist5® Ventricular Assist Device (VAD) has attained CE Mark approval for design enhancements. The CE Mark which includes remote monitoring via VADLink.com provides remote and true flow measurement of the HeartAssist5®. The HeartAssist5® (HA5) measures True Flow. Flow is not estimated, it is accurately measured. Now True Flow is available over… Read more »
Houston, Texas. November 20, 2013 — ReliantHeart, Inc. the manufacturer of the HeartAssist5® Ventricular Assist Device (VAD) has appointed to its Board of Directors Michael E. Gerber, writer of best-selling book The E-Myth Revisited and well-known legend of entrepreneurship. INC. Magazine called Gerber “the World’s #1 Business Guru,” with his forty years of experience in addressing… Read more »
Houston, Texas. November 18, 2013 — ReliantHeart, Inc. the manufacturer of the HeartAssist5® Ventricular Assist Device (VAD) has appointed John V. Soden of Houlihan Lokey to its Board of Directors. Soden has nearly two decades of experience in investment banking. He is a Managing Director of the Healthcare Group for investment bank Houlihan Lokey where… Read more »
Houston, Texas. November 10, 2013 – The ReliantHeart HeartAssist5® Ventricular Assist Device (VAD) has been CE Mark* approved in Europe for use in patients requiring ventricular support due to end stage heart failure. The HeartAssist5® is approved for bridge to transplant (BTT) patients awaiting cardiac transplantation and for destination therapy (DT) patients who are not… Read more »
Breakthrough Technology Advances Remote Monitoring Capabilities of the HeartAssist5® System to Wirelessly Report Data when Patients are on the Move
